Perjeta Side Effects
Generic name: pertuzumab
Medically reviewed by Drugs.com. Last updated on Dec 15, 2024.
Note: This document provides detailed information about Perjeta Side Effects associated with pertuzumab. Some dosage forms listed on this page may not apply specifically to the brand name Perjeta.
Applies to pertuzumab: intravenous solution.
Important warnings
This medicine can cause some serious health issues
Intravenous route (solution)
Pertuzumab can result in subclinical and clinical cardiac failure manifesting as decreased left ventricular ejection fraction and congestive heart failure.
Evaluate cardiac function prior to and during treatment.
Discontinue pertuzumab treatment for a confirmed clinically significant decrease in left ventricular function.
Exposure to pertuzumab can result in embryo-fetal death and birth defects.
Advise patients of these risks and the need for effective contraception.
Precautions
It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly and to check for unwanted effects. Be sure to keep all appointments.
Your unborn baby could be harmed if you use this medicine while you are pregnant. Use an effective form of birth control to keep from getting pregnant during treatment with this medicine and for 7 months after the last dose. Tell your doctor right away if you think you have become pregnant.
This medicine may cause heart failure. Your doctor will test your heart before you start receiving pertuzumab (the active ingredient contained in Perjeta) The test will be repeated every few months while you are receiving the medicine. Check with your doctor right away if you have chest pain, trouble breathing, rapid weight gain, or abnormal swelling in your ankles or legs. These could be symptoms of heart failure.
This medicine may cause a serious infusion reaction. This can be life-threatening and requires immediate medical attention. Tell your doctor or nurse right away if you have a fever, chills, chest pain, lightheadedness, dizziness, fainting, a headache, a rash, pain, nausea, vomiting, trouble breathing, or weakness within a few hours after the infusion.
This medicine may cause serious allergic reactions, including anaphylaxis, which can be life-threatening and requires immediate medical attention. Call your doctor right away if you have a rash, itching, trouble breathing, trouble swallowing, or any swelling of your hands, face, or mouth after you get the injection.
Cancer medicines can cause nausea or vomiting in most people, sometimes even after receiving medicines to prevent it. If this happens, ask your doctor or nurse about other ways to control these side effects.
Serious side effects of Perjeta
Along with its needed effects, pertuzumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking pertuzumab:
More common side effects
- black, tarry stools
- burning, numbness, tingling, or painful sensations
- chills
- cough
- fast heartbeat
- fever
- hives, itching, or rash
- hoarseness
- joint pain, stiffness, or swelling
- lower back or side pain
- painful or difficult urination
- pale skin
- redness of the skin
- sore throat
- swelling of the eyelids, face, lips, hands, or feet
- tightness in the chest
- troubled breathing or swallowing
- ulcers, sores, or white spots in the mouth
- unsteadiness or awkwardness
- unusual bleeding or bruising
- unusual tiredness or weakness
- weakness in the arms, hands, legs, or feet
Other side effects of Perjeta
Some side effects of pertuzumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- body aches or pain
- change in taste
- cracked lips
- decreased appetite
- diarrhea
- dizziness
- dry skin
- ear congestion
- hair loss or thinning of the hair
- headache
- loosening of the fingernails
- loss of taste
- loss of voice
- nasal congestion
- nausea
- redness or soreness around the fingernails
- runny nose
- sneezing
- vomiting
- watering of the eyes
For healthcare professionals
Applies to pertuzumab: intravenous solution.
Cardiovascular adverse events
- Common (1% to 10%): Left ventricular dysfunction (including congestive heart failure)[Ref]
Dermatologic
- Very common (10% or more): Alopecia (61%), rash (34%), nail disorder (23%), pruritus (14%)
- Common (1% to 10%): Dry skin, palmar-plantar erythrodysesthesia syndrome[Ref]
Gastrointestinal
- Very common (10% or more): Diarrhea (67%), nausea (42%), mucositis/mucosal inflammation (28%), constipation (25%), vomiting (24%), stomatitis (19%), dyspepsia (12%)[Ref]
Hematologic
- Very common (10% or more): Neutropenia (53%), anemia (23%), leucopenia (20%), febrile neutropenia (13%)[Ref]
Hypersensitivity
- Very common (10% or more): Hypersensitivity/anaphylactic reaction, infusion reaction/cytokine release syndrome[Ref]
Metabolic
- Very common (10% or more): Decreased appetite (29%)[Ref]
Musculoskeletal
- Very common (10% or more): Myalgia (24%), arthralgia (15%), pain in extremity (15%)[Ref]
Nervous system
- Very common (10% or more): Peripheral neuropathy (21%), headache (21%), dysgeusia (18%), peripheral sensory neuropathy (14%), dizziness (13%)[Ref]
Ocular
- Very common (10% or more): Increased lacrimation (14%)[Ref]
Psychiatric
- Very common (10% or more): Insomnia (13%)[Ref]
Respiratory
- Very common (10% or more): Cough (21%), upper respiratory tract infection (17%), dyspnea (16%), nasopharyngitis (13%)
- Common (1% to 10%): Paronychia, pleural effusion, epistaxis
- Uncommon (0.1% to 1%): Interstitial lung disease[Ref]
Other
- Very common (10% or more): Fatigue (38%), peripheral edema (30%), asthenia (30%), pyrexia (19%), pain
- Common (1% to 10%): Chills[Ref]
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
2. Cerner Multum, Inc. "Australian Product Information."
3. (2012) "Product Information. Perjeta (pertuzumab)." Genentech
Frequently asked questions
- What is TCHP chemotherapy and how is it used?
- How long can you stay on Herceptin and Perjeta?
- How much does Perjeta cost?
- Is Perjeta a chemotherapy drug?
- What common side effects occur with Perjeta?
- How long do Perjeta infusions last?
- How do Herceptin (trastuzumab) and Perjeta (pertuzumab) work together?
More about Perjeta (pertuzumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Perjeta side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.